MARY CAPSTACK: Open Payments
NPI 1508258013 · HARRISONBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 36 payments from 9 companies in 2025. Trend: 2023 $698 · 2024 $1,016 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $212 |
| Janssen Biotech, Inc. | 8 | $204 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Ardelyx, Inc. | 5 | $81 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Celltrion USA Inc. | 2 | $53 |
| Madrigal Pharmaceuticals | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, IBSRELA, CREON, IQIRVO, DUPIXENT, VEGZELMA, XIFAXAN.
Industry payments across VA — which companies pay providers there.
